LYNCH RYAN (See Remarks) received a stock award from CRESCENT BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 12/17/2025ACC: 0001628280-25-057671
Officer· See Remarks
Since Jun 2025
+45.89K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
45.89K acquired
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+8.38K
Price / share
—
Trade value
—
% of position
New position
12/15/2025
0.00→8.38K
Ordinary Shares
Direct
Shares
+4K
Price / share
—
Trade value
—
% of position
47.7%
12/15/2025
8.38K→12.38K
Total
Net shares
+12.38K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 12/15/2025 | A · Award | +8.38K | — | — | New position | 0.00 | 8.38K |
| Ordinary Shares Direct | 12/15/2025 | A · Award | +4K | — | — | 47.7% | 8.38K | 12.38K |
| Total | +12.38K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
33.51K shares
Shares
+33.51K
Strike price
13.21
Held after
33.51K
Exercisable
—
12/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares33.51K shares | 12/15/2025 | A · Award | +33.51K | 13.21 | — | 33.51K |